gabapentine effect on post operative nausea and vomiting
Phase 3
- Conditions
- nausea and vomiting.-
- Registration Number
- IRCT2016100230072N2
- Lead Sponsor
- Anesthisia research centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 116
Inclusion Criteria
Age 18 to 60 years old; ASA I&II ;early surgical excision and graft in
Burned patient
Exclusion criteria:
Addiction; smoker; alcoholic patient; use of antiemetic; anti acid; analgesic; anti depressant; ca Chanel blocker; renal and hepatic insufficiency; underlying disease leading to nausea and vomiting; pregnancy; lactating; allergy to gabapentin or opium and motion sickness
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea. Timepoint: PACU (T0) 6 hr post surgery (T1) 12 hr post surgery (T2) 18 hr post surgery (T3) 24 hr post surgery (T4). Method of measurement: vas score.;Vomitting. Timepoint: PACU (T0) 6 hr post surgery (T1) 12 hr post surgery (T2) 18 hr post surgery (T3) 24 hr post surgery (T4). Method of measurement: frequency.
- Secondary Outcome Measures
Name Time Method Pain. Timepoint: PACU (T0) 6 hr post surgery (T1) 12 hr post surgery (T2) 18 hr post surgery (T3) 24 hr post surgery (T4). Method of measurement: vas.